Market Cap 239.78M
Revenue (ttm) 2.04M
Net Income (ttm) -40.83M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,001.47%
Debt to Equity Ratio 11.40
Volume 5,584,100
Avg Vol 6,824,192
Day's Range N/A - N/A
Shares Out 222.02M
Stochastic %K 91%
Beta 2.31
Analysts Strong Sell
Price Target $5.07

Company Profile

Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It...

Industry: Biotechnology
Sector: Healthcare
Phone: 919 313 9633
Address:
2525 East North Carolina Highway 54, Durham, United States
audiobookprisonstories
audiobookprisonstories May. 9 at 1:03 AM
$HUMA i will KEEP YOU POSTED ON HUMA DAY BY DAY. MY BIGGEST INVESTMENT YET. I SEE AN OVER 80% CHANCE FOR GREAT DATA. POTENTIAL IS ON THE HIGH END OF $5-7 AT DATA RELEASE JUNE 11, ON THE LOWER END OF GREAT DATA $3-4. WE HAVE LESS THAN 20% CHANCE OF FAILURE IMO. TODAY HUMA Order Flow Recap (Today): Inflow ~$902K vs Outflow ~$707K → buyers in control (~1.3:1). Flow was steady with medium-sized orders leading, suggesting quiet accumulation rather than aggressive chasing. Price held firm and continued pressing into the $1.06–$1.08 resistance zone, where sell liquidity is still absorbing demand. This is constructive: not a breakout yet, but building pressure under resistance. 👉 Key next move: needs a volume expansion + stronger large-order buying to punch through that wall. If that happens, the next logical push opens toward the $1.20+ range. For now: controlled accumulation, coiling setup, watching for volume spike to confirm breakout.
1 · Reply
LostinNikla
LostinNikla May. 8 at 11:53 PM
$HUMA So just spilballing, but the shorts seem to be organized well on how to bring the stock back down, If the Longs did just the oppiosite I wonder if we could get in trouble?
0 · Reply
crowbaby333
crowbaby333 May. 8 at 9:01 PM
$HUMA 2/10 days closed over $1.00 8 more days. But even if not I highly suspect we will get there before the 6/11 data date
1 · Reply
jacksparo
jacksparo May. 8 at 8:59 PM
$CADL Strong close for the week . Next week might be the most anticipated one!! $SLS Nice turn from red to green ✅✅ $IBRX My Live Biotech group I shared with you the plan in the beginning of the week You can go make a look at the chart and see how all predictions came in line . What a strong close for the week! $OCGN Key word is a one word here: Patience!! $HUMA It needs another 7 days with closing above 1 to bring in more attention… So far still holding half of what I got back when it was around 0.60 Not bad at all! Remember all my Live updates I share in my Live Biotech telegram group! Enjoy your Friday night and your weekend 📈📈📈!
2 · Reply
PatSoonDiggler
PatSoonDiggler May. 8 at 7:05 PM
$HUMA Just picked up 10,000 more shares today. LFG!!!
2 · Reply
malphius
malphius May. 8 at 6:17 PM
$EXAS Did you know there is an overlap with $HUMA and the board of directors? Did you know that 1 share of EXAS will buy 100 shares of $HUMA right before their June 11 V012 Phase 3 catalyst to unlock the Dialysis market?
1 · Reply
moneyisfunduhr
moneyisfunduhr May. 8 at 6:06 PM
$HUMA LAURA FCKING BUY SOME SHARES YOU OLD HAG
1 · Reply
malphius
malphius May. 8 at 5:54 PM
$HUMA Here is the other company Kathleen Sebelius is involved with. This will be HUMA in a few years:
0 · Reply
moneyisfunduhr
moneyisfunduhr May. 8 at 5:47 PM
$HUMA buy buy buy
0 · Reply
moneyisfunduhr
moneyisfunduhr May. 8 at 5:38 PM
$HUMA barcode volume pattern lol
0 · Reply
Latest News on HUMA
Humacyte Transcript: KOL event

Apr 28, 2026, 8:00 AM EDT - 10 days ago

Humacyte Transcript: KOL event


Humacyte Appoints Jim Mercadante as Chief Commercial Officer

Apr 22, 2026, 8:00 AM EDT - 16 days ago

Humacyte Appoints Jim Mercadante as Chief Commercial Officer


Humacyte price target lowered to $1.50 from $3.50 at Barclays

2026-04-08T09:30:25.000Z - 4 weeks ago

Humacyte price target lowered to $1.50 from $3.50 at Barclays


Humacyte downgraded to Speculative Buy from Buy at Benchmark

2026-03-31T13:30:42.000Z - 5 weeks ago

Humacyte downgraded to Speculative Buy from Buy at Benchmark


Humacyte price target lowered to $1 from $3.50 at TD Cowen

2026-03-30T12:05:04.000Z - 5 weeks ago

Humacyte price target lowered to $1 from $3.50 at TD Cowen


Humacyte price target lowered to $1 from $3 at Piper Sandler

2026-03-30T11:58:53.000Z - 5 weeks ago

Humacyte price target lowered to $1 from $3 at Piper Sandler


Humacyte Earnings Call Transcript: Q4 2025

Mar 27, 2026, 8:00 AM EDT - 6 weeks ago

Humacyte Earnings Call Transcript: Q4 2025


Humacyte reports Q4 EPS (13c), consensus (14c)

2026-03-27T11:22:11.000Z - 6 weeks ago

Humacyte reports Q4 EPS (13c), consensus (14c)


Humacyte prices $20M registered direct offering

2026-03-19T12:36:23.000Z - 7 weeks ago

Humacyte prices $20M registered direct offering


Humacyte receives Symvess purchase commitment

2026-03-19T12:36:11.000Z - 7 weeks ago

Humacyte receives Symvess purchase commitment


Humacyte Transcript: TD Cowen 46th Annual Health Care Conference

Mar 4, 2026, 10:30 AM EST - 2 months ago

Humacyte Transcript: TD Cowen 46th Annual Health Care Conference


Humacyte To Participate in Upcoming Investor Conferences

Mar 2, 2026, 8:00 AM EST - 2 months ago

Humacyte To Participate in Upcoming Investor Conferences


Humacyte price target lowered to $10 from $11 at Benchmark

2026-01-21T13:16:04.000Z - 3 months ago

Humacyte price target lowered to $10 from $11 at Benchmark


Humacyte Earnings Call Transcript: Q3 2025

Nov 12, 2025, 8:00 AM EST - 6 months ago

Humacyte Earnings Call Transcript: Q3 2025


Humacyte Earnings Call Transcript: Q2 2025

Aug 11, 2025, 8:00 AM EDT - 9 months ago

Humacyte Earnings Call Transcript: Q2 2025


Humacyte Earnings Call Transcript: Q1 2025

May 13, 2025, 8:30 AM EDT - 1 year ago

Humacyte Earnings Call Transcript: Q1 2025


Humacyte Earnings Call Transcript: Q4 2024

Mar 28, 2025, 8:30 AM EDT - 1 year ago

Humacyte Earnings Call Transcript: Q4 2024


Humacyte Transcript: Investor Update

Mar 6, 2025, 12:00 PM EST - 1 year ago

Humacyte Transcript: Investor Update


Trestle Bio Announces Research Collaboration with Humacyte

Mar 6, 2025, 8:00 AM EST - 1 year ago

Trestle Bio Announces Research Collaboration with Humacyte


audiobookprisonstories
audiobookprisonstories May. 9 at 1:03 AM
$HUMA i will KEEP YOU POSTED ON HUMA DAY BY DAY. MY BIGGEST INVESTMENT YET. I SEE AN OVER 80% CHANCE FOR GREAT DATA. POTENTIAL IS ON THE HIGH END OF $5-7 AT DATA RELEASE JUNE 11, ON THE LOWER END OF GREAT DATA $3-4. WE HAVE LESS THAN 20% CHANCE OF FAILURE IMO. TODAY HUMA Order Flow Recap (Today): Inflow ~$902K vs Outflow ~$707K → buyers in control (~1.3:1). Flow was steady with medium-sized orders leading, suggesting quiet accumulation rather than aggressive chasing. Price held firm and continued pressing into the $1.06–$1.08 resistance zone, where sell liquidity is still absorbing demand. This is constructive: not a breakout yet, but building pressure under resistance. 👉 Key next move: needs a volume expansion + stronger large-order buying to punch through that wall. If that happens, the next logical push opens toward the $1.20+ range. For now: controlled accumulation, coiling setup, watching for volume spike to confirm breakout.
1 · Reply
LostinNikla
LostinNikla May. 8 at 11:53 PM
$HUMA So just spilballing, but the shorts seem to be organized well on how to bring the stock back down, If the Longs did just the oppiosite I wonder if we could get in trouble?
0 · Reply
crowbaby333
crowbaby333 May. 8 at 9:01 PM
$HUMA 2/10 days closed over $1.00 8 more days. But even if not I highly suspect we will get there before the 6/11 data date
1 · Reply
jacksparo
jacksparo May. 8 at 8:59 PM
$CADL Strong close for the week . Next week might be the most anticipated one!! $SLS Nice turn from red to green ✅✅ $IBRX My Live Biotech group I shared with you the plan in the beginning of the week You can go make a look at the chart and see how all predictions came in line . What a strong close for the week! $OCGN Key word is a one word here: Patience!! $HUMA It needs another 7 days with closing above 1 to bring in more attention… So far still holding half of what I got back when it was around 0.60 Not bad at all! Remember all my Live updates I share in my Live Biotech telegram group! Enjoy your Friday night and your weekend 📈📈📈!
2 · Reply
PatSoonDiggler
PatSoonDiggler May. 8 at 7:05 PM
$HUMA Just picked up 10,000 more shares today. LFG!!!
2 · Reply
malphius
malphius May. 8 at 6:17 PM
$EXAS Did you know there is an overlap with $HUMA and the board of directors? Did you know that 1 share of EXAS will buy 100 shares of $HUMA right before their June 11 V012 Phase 3 catalyst to unlock the Dialysis market?
1 · Reply
moneyisfunduhr
moneyisfunduhr May. 8 at 6:06 PM
$HUMA LAURA FCKING BUY SOME SHARES YOU OLD HAG
1 · Reply
malphius
malphius May. 8 at 5:54 PM
$HUMA Here is the other company Kathleen Sebelius is involved with. This will be HUMA in a few years:
0 · Reply
moneyisfunduhr
moneyisfunduhr May. 8 at 5:47 PM
$HUMA buy buy buy
0 · Reply
moneyisfunduhr
moneyisfunduhr May. 8 at 5:38 PM
$HUMA barcode volume pattern lol
0 · Reply
Runmaster83
Runmaster83 May. 8 at 5:29 PM
$HUMA Makary out at FDA per WSJ…
0 · Reply
Brutusmabel
Brutusmabel May. 8 at 4:55 PM
$HUMA thing are heating up!! 🥵
0 · Reply
Brutusmabel
Brutusmabel May. 8 at 4:44 PM
$HUMA can someone please get up and whack the side of the tv…….younger guys won’t get it 😂
0 · Reply
Brutusmabel
Brutusmabel May. 8 at 3:40 PM
$HUMA kinda rough when people aren’t hitting the ask on such a huge squeeze
1 · Reply
moneyisfunduhr
moneyisfunduhr May. 8 at 3:08 PM
$HUMA LOAD UP!!!
0 · Reply
Runmaster83
Runmaster83 May. 8 at 2:44 PM
$HUMA Hey Shorts…..😘
0 · Reply
malphius
malphius May. 8 at 2:26 PM
$HUMA Keep it over $1 you greedy degens.
0 · Reply
Pitchie
Pitchie May. 8 at 2:11 PM
$HUMA https://finance.yahoo.com/sectors/healthcare/articles/humacyte-announce-2026-first-quarter-120000803.html
0 · Reply
Brutusmabel
Brutusmabel May. 8 at 2:04 PM
$HUMA I added 1k , more to just try and help the cause because it raised my avg 😂
0 · Reply
Rybod30
Rybod30 May. 8 at 1:58 PM
$HUMA Earnings won’t help here, unfortunately…
1 · Reply
malphius
malphius May. 8 at 1:57 PM
$HUMA Shorts reload every morning at market open to make you think there is a selloff.
0 · Reply
audiobookprisonstories
audiobookprisonstories May. 8 at 1:52 PM
$HUMA I WILL TRY TO UPDATE YOU GUYS LATER. RIGHT NOW ORDER FLOW IS 1.6 BUYERS TO SELLERS. MEDIUM SIZED BUYERS, NOT BIG INSTITUTIONS YET. WE COULD CHOP TODAY BUT DO NOT SELL FOR PENNIES YET. WE SHOULD GET UP TO $1.50 EASY INTO DATA RELEASE. THEN LIKELY 100% MOVE IF DATA IS BETTER THAN STANDARD OF CARE. IF IT IS WAY BETTER WE RUN FOR DAYS OR WEEKS! IF IT IS QUESTIONABLY BETTER WHO KNOWS FOR SURE AS IT IS A FIGHT TO ADOPT... BUT I THINK IF FRESNIUS IS IN AT $9 PER SHARE AND INSIDERS ARE IN OVER $1.50 WE ARE GETTING GOOD BUYS DOWN HERE.
1 · Reply